Product Information
APTENSIO XR 60 MG CAPSULE is a brand product labeled by Rhodes Pharmaceuticals L.P., priced at $8.0386 per EA under NDC 42858040745. Its NADAC has been published 248 times since Jan 23, 2019.
FDA first approved this application on Apr 17, 2015. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
60 mg/1
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858040745
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
7/23/2025
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA205831FDA Approved
4/17/2015
TE Code
AB3
On Market Since
4/17/2015
Pharmacological Classes
Price Statistics
The NADAC for APTENSIO XR 60 MG CAPSULE has been published 248 times since Jan 23, 2019, and over the history we have for it it has risen 6.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.0386 per EA |
|---|---|
| All-time high | $8.0522 (Jun 11, 2025) |
| All-time low | $7.5630 (Jan 23, 2019) |
| 52-week high | $8.0386 |
| 52-week low | $8.0386 |
| Median price | $8.0303 |
| Average price | $7.9766 |
| Largest weekly change | +6.0% (Aug 7, 2019) |
| Weeks tracked | 248 |
| Tracking since | Jan 23, 2019 |
1W
N/A
1M
N/A
3M
0.0%
6M
0.0%
1Y
0.0%
3Y
+0.1%
5Y
+0.1%
All
+6.3%
Last surveyed Jul 15, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 78% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of APTENSIO XR 60 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for APTENSIO XR 60 MG CAPSULE, manufactured by Rhodes Pharmaceuticals L.P., is $8.0386 per EA (NDC 42858040745), effective Jul 15, 2026.
How has the price of APTENSIO XR 60 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for APTENSIO XR 60 MG CAPSULE has risen 6.3%. It has been tracked across 248 weekly CMS publications since Jan 23, 2019.
What are the highest and lowest recorded NADAC prices for APTENSIO XR 60 MG CAPSULE?
Since Jan 23, 2019, the NADAC for APTENSIO XR 60 MG CAPSULE has ranged from a low of $7.5630 (Jan 23, 2019) to a high of $8.0522 (Jun 11, 2025), with a median of $8.0303 per EA.
Are there cheaper alternatives to APTENSIO XR 60 MG CAPSULE?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE CD 60 MG CAP, is $1.7655 per EA — about 78% below APTENSIO XR 60 MG CAPSULE.
Who manufactures APTENSIO XR 60 MG CAPSULE?
APTENSIO XR 60 MG CAPSULE (NDC 42858040745) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a brand product.